{"schema_version":"1","generated_at":"2026-11-02T15:36:03.097Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/abby-rosenberg","json_url":"https://www.findmykol.com/kol/abby-rosenberg/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"abby-rosenberg","name":"Abby Rosenberg","credential":"MD","title":"Director, Pediatric Palliative Care","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma"],"institution":"Boston Children's Hospital","institution_url":"https://www.findmykol.com/institution/boston-children-s-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1194833020","orcid":"0000-0003-0785-5661","openalex":"A5102784725"},"summary":"Abby Rosenberg is Director, Pediatric Palliative Care at Boston Children's Hospital. OpenAlex indexes 10 publications with 224 citations (h-index 6); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"Abby R. Rosenberg is Director, Pediatric Palliative Care at Boston Children's Hospital. The public record shows 10 publications with 224 citations (h-index 6), centered on Health Systems, Economic Evaluations, Quality of Life, Nonmelanoma Skin Cancer Studies, Cutaneous lymphoproliferative disorders research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2022–2026).","bullets":["Most recent indexed publication: 2021 · The British journal of dermatology","Top research focus: Health Systems, Economic Evaluations, Quality of Life","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-11-02"},"focus":{"indications":[{"label":"Depression (MDD)","therapeutic_area":"Psychiatry","trials":2,"topics":0,"strength":6},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Myeloid, Acute","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Coma","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Neoplasms, Germ Cell and Embryonal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Bone Marrow Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Health Systems, Economic Evaluations, Quality of Life","Nonmelanoma Skin Cancer Studies","Cutaneous lymphoproliferative disorders research","Cancer survivorship and care","Cutaneous Melanoma Detection and Management"],"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Dana-Farber Cancer Institute","trials":2,"payments":0,"mentions":2},{"name":"Seattle Children's Hospital","trials":2,"payments":0,"mentions":2},{"name":"GlaxoSmithKline, LLC.","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":10,"cited_by_count":224,"h_index":6,"i10_index":4,"pubmed_count":2,"latest_activity_year":2026,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06038318","title":"Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06038318","trial_url":"https://www.findmykol.com/trial/NCT06038318"},{"nct":"NCT03668223","title":"The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Dana-Farber Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT03668223","trial_url":"https://www.findmykol.com/trial/NCT03668223"},{"nct":"NCT03640325","title":"The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Seattle Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT03640325","trial_url":"https://www.findmykol.com/trial/NCT03640325"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2023,"last":2023},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"GlaxoSmithKline, LLC.","program_year":2023,"amount_usd":112.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194833020"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1194833020","source":"payments"},"funding":{"award_count":5,"fiscal_years":{"first":2022,"last":2026},"rows_total":28,"shown":3,"withheld":25,"rows":[{"project":"R01CA269574","title":"Promoting Resilience in Early Survivorship among Adolescents and Young Adults with Cancer","fiscal_year":2026,"amount_usd":788243,"organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/R01CA269574"},{"project":"R25CA181000","title":"Workshop on Research Methods in Supportive Oncology","fiscal_year":2026,"amount_usd":182289,"organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/R25CA181000"},{"project":"K24HL173664","title":"Collaborative Care to Improve Resilience and Quality of Life among Youth with Non-malignant Blood Disorders","fiscal_year":2026,"amount_usd":124917,"organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K24HL173664"}],"source":"grants"},"publications":{"total":2,"shown":2,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.","year":2021,"journal":"The British journal of dermatology","types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/32510571/","status":"verified"},{"title":"Health-related quality of life and economic implications of cutaneous T-cell lymphoma.","year":2020,"journal":"The British journal of dermatology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/30920642/","status":"verified"}],"most_cited":{"total":10,"shown":5,"withheld":5,"rows":[{"title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","year":2019,"cited_by_count":107,"type":"article","source_url":"https://doi.org/10.1172/jci.insight.125476"},{"title":"Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma","year":2019,"cited_by_count":35,"type":"article","source_url":"https://doi.org/10.1111/bjd.17941"},{"title":"Clinical severity measures and quality‐of‐life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology‐specific instruments","year":2019,"cited_by_count":34,"type":"article","source_url":"https://doi.org/10.1111/jdv.16021"},{"title":"Current measures are not sufficient: an interview‐based qualitative assessment of quality of life in cutaneous T‐cell lymphoma*","year":2020,"cited_by_count":28,"type":"article","source_url":"https://doi.org/10.1111/bjd.19298"},{"title":"Patient Concerns About Nasal Reconstruction After Mohs Surgery and Implications for Shared Decision Making","year":2018,"cited_by_count":8,"type":"article","source_url":"https://doi.org/10.1001/jamaoto.2018.2368"}]},"source":"publications"},"network":{"coauthors_total":23,"shown":3,"withheld":20,"coauthors":[{"name":"Yevgeniy R. Semenov","coauthored_works":7},{"name":"Amy C. M. Musiek","coauthored_works":5},{"name":"Christina M. Herbosa","coauthored_works":5}],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, MS, MA","source_url":"https://bchcmg.tch.harvard.edu/directory/abby-rosenberg","status":"provisional","collected_at":"2026-11-02"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"2021 Trish Greene Quality of Life Award, American Cancer Society","source_url":"https://pressroom.cancer.org/2022-06-27-American-Cancer-Society-Honors-Dr-Abby-R-Rosenberg-with-Prestigious-Trish-Greene-Quality-of-Life-Award","status":"verified","collected_at":"2026-11-02"}]}},"similar":[{"name":"Jane Newburger","slug":"jane-newburger","institution":"Boston Children's Hospital","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/jane-newburger","json_url":"https://www.findmykol.com/kol/jane-newburger/profile.json"},{"name":"Christopher Duggan","slug":"christopher-duggan","institution":"Boston Children's Hospital","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/christopher-duggan","json_url":"https://www.findmykol.com/kol/christopher-duggan/profile.json"},{"name":"Samuel Nurko","slug":"samuel-nurko","institution":"Boston Children's Hospital","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/samuel-nurko","json_url":"https://www.findmykol.com/kol/samuel-nurko/profile.json"},{"name":"Maureen Jonas","slug":"maureen-jonas","institution":"Boston Children's Hospital","specialty":"Pediatric Transplant Hepatology","url":"https://www.findmykol.com/kol/maureen-jonas","json_url":"https://www.findmykol.com/kol/maureen-jonas/profile.json"},{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"Omid Hamid","slug":"omid-hamid","institution":"The Angeles Clinic and Research Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/omid-hamid","json_url":"https://www.findmykol.com/kol/omid-hamid/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"funding":25,"network":20}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-02"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-02"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2023 to 2023","collected_at":"2026-11-02"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-02"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-02"}},"methodology_url":"https://www.findmykol.com/about#methodology"}